Professor and Chair, Division of Endocrinology
Queen's University
Queen's University
Kingston, Ontario, Canada
Dr. Robyn Houlden is Professor and Chair of the Division of Endocrinology at Queen’s University, and a consultant in adult endocrinology at the Kingston Health Sciences Centre. She has served as a diabetes advisor for the Canadian Optimal Medication Prescribing and Utilization Service of the Canadian Agency for Drugs and Technologies in Health, and the Ontario Ministry of Health. She is a member of the eConsult/eReferral Clinical Advisory Group for the Ontario Ministry of Health, and a provincial provider for eConsults in Endocrinology. She has been an investigator in a number of clinical trials of new therapies for diabetes, and has a research interest in innovative models of diabetes health care delivery. She has published over 150 peer reviewed papers. She has been involved in the Diabetes Canada Clinical Practice Guidelines for over 20 years, and chaired the 2018 edition. Throughout her career, she has been the recipient of several honours and awards. She has been recognized with 20 teaching awards including the Queen’s Department of Medicine Master Educator Award and the Canadian Society of Endocrinology and Metabolism Educator Award. In 2002, she was awarded the Charles H. Best Award by Diabetes Canada for her advocacy work in diabetes. In 2024, she was awarded the Canadian Society of Endocrinology and Metabolism Robert Volpe Distinguished Service Award.
Friday, November 22, 2024
16:00 - 17:15 AT Time
Disclosure(s): Abbott Canada: Speaker/Honoraria (Ongoing); Astra Zeneca: Speaker/Honoraria (Ongoing); Biocon Biologics: Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Speaker/Honoraria (Ongoing); Dexcom Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic: Speaker/Honoraria (Ongoing); Novo Nordisk Canada Inc.: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Tandem: Speaker/Honoraria (Ongoing)